Global Pediatric Gastrointestinal Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 126

Published Date: 20 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Pediatric Gastrointestinal Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Pediatric Gastrointestinal Drugs industry chain, the market status of Hospital Pharmacies (Tablets, Pills), Online Pharmacies (Tablets, Pills), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pediatric Gastrointestinal Drugs.

Regionally, the report analyzes the Pediatric Gastrointestinal Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pediatric Gastrointestinal Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Pediatric Gastrointestinal Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pediatric Gastrointestinal Drugs industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tablets, Pills).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pediatric Gastrointestinal Drugs market.

Regional Analysis: The report involves examining the Pediatric Gastrointestinal Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pediatric Gastrointestinal Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Pediatric Gastrointestinal Drugs:
Company Analysis: Report covers individual Pediatric Gastrointestinal Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pediatric Gastrointestinal Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Online Pharmacies).

Technology Analysis: Report covers specific technologies relevant to Pediatric Gastrointestinal Drugs. It assesses the current state, advancements, and potential future developments in Pediatric Gastrointestinal Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pediatric Gastrointestinal Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Pediatric Gastrointestinal Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Tablets
Pills
Oral Liquid

Market segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market segment by players, this report covers
AstraZeneca
Sanofi
Aptalis
Eisai
Pfizer
Zeria (Tillotts)
GlaxoSmithKline
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Hansen Pharmaceutical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pediatric Gastrointestinal Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pediatric Gastrointestinal Drugs, with revenue, gross margin and global market share of Pediatric Gastrointestinal Drugs from 2019 to 2024.
Chapter 3, the Pediatric Gastrointestinal Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pediatric Gastrointestinal Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pediatric Gastrointestinal Drugs.
Chapter 13, to describe Pediatric Gastrointestinal Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Pediatric Gastrointestinal Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Pediatric Gastrointestinal Drugs by Type
        1.3.1 Overview: Global Pediatric Gastrointestinal Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Pediatric Gastrointestinal Drugs Consumption Value Market Share by Type in 2023
        1.3.3 Tablets
        1.3.4 Pills
        1.3.5 Oral Liquid
    1.4 Global Pediatric Gastrointestinal Drugs Market by Application
        1.4.1 Overview: Global Pediatric Gastrointestinal Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital Pharmacies
        1.4.3 Online Pharmacies
        1.4.4 Retail Pharmacies
    1.5 Global Pediatric Gastrointestinal Drugs Market Size & Forecast
    1.6 Global Pediatric Gastrointestinal Drugs Market Size and Forecast by Region
        1.6.1 Global Pediatric Gastrointestinal Drugs Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Pediatric Gastrointestinal Drugs Market Size by Region, (2019-2030)
        1.6.3 North America Pediatric Gastrointestinal Drugs Market Size and Prospect (2019-2030)
        1.6.4 Europe Pediatric Gastrointestinal Drugs Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size and Prospect (2019-2030)
        1.6.6 South America Pediatric Gastrointestinal Drugs Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Pediatric Gastrointestinal Drugs Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 AstraZeneca
        2.1.1 AstraZeneca Details
        2.1.2 AstraZeneca Major Business
        2.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Product and Solutions
        2.1.4 AstraZeneca Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 AstraZeneca Recent Developments and Future Plans
    2.2 Sanofi
        2.2.1 Sanofi Details
        2.2.2 Sanofi Major Business
        2.2.3 Sanofi Pediatric Gastrointestinal Drugs Product and Solutions
        2.2.4 Sanofi Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sanofi Recent Developments and Future Plans
    2.3 Aptalis
        2.3.1 Aptalis Details
        2.3.2 Aptalis Major Business
        2.3.3 Aptalis Pediatric Gastrointestinal Drugs Product and Solutions
        2.3.4 Aptalis Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Aptalis Recent Developments and Future Plans
    2.4 Eisai
        2.4.1 Eisai Details
        2.4.2 Eisai Major Business
        2.4.3 Eisai Pediatric Gastrointestinal Drugs Product and Solutions
        2.4.4 Eisai Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Eisai Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Pediatric Gastrointestinal Drugs Product and Solutions
        2.5.4 Pfizer Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Zeria (Tillotts)
        2.6.1 Zeria (Tillotts) Details
        2.6.2 Zeria (Tillotts) Major Business
        2.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product and Solutions
        2.6.4 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Zeria (Tillotts) Recent Developments and Future Plans
    2.7 GlaxoSmithKline
        2.7.1 GlaxoSmithKline Details
        2.7.2 GlaxoSmithKline Major Business
        2.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Product and Solutions
        2.7.4 GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 GlaxoSmithKline Recent Developments and Future Plans
    2.8 Salix Pharmaceuticals
        2.8.1 Salix Pharmaceuticals Details
        2.8.2 Salix Pharmaceuticals Major Business
        2.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product and Solutions
        2.8.4 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Salix Pharmaceuticals Recent Developments and Future Plans
    2.9 Perrigo
        2.9.1 Perrigo Details
        2.9.2 Perrigo Major Business
        2.9.3 Perrigo Pediatric Gastrointestinal Drugs Product and Solutions
        2.9.4 Perrigo Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Perrigo Recent Developments and Future Plans
    2.10 Abbott
        2.10.1 Abbott Details
        2.10.2 Abbott Major Business
        2.10.3 Abbott Pediatric Gastrointestinal Drugs Product and Solutions
        2.10.4 Abbott Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Abbott Recent Developments and Future Plans
    2.11 Honz Pharmaceutical
        2.11.1 Honz Pharmaceutical Details
        2.11.2 Honz Pharmaceutical Major Business
        2.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
        2.11.4 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Honz Pharmaceutical Recent Developments and Future Plans
    2.12 Shandong DYNE Marine Biopharmaceutical
        2.12.1 Shandong DYNE Marine Biopharmaceutical Details
        2.12.2 Shandong DYNE Marine Biopharmaceutical Major Business
        2.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
        2.12.4 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Shandong DYNE Marine Biopharmaceutical Recent Developments and Future Plans
    2.13 Sunflower Pharmaceutical
        2.13.1 Sunflower Pharmaceutical Details
        2.13.2 Sunflower Pharmaceutical Major Business
        2.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
        2.13.4 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Sunflower Pharmaceutical Recent Developments and Future Plans
    2.14 Jiangzhong Pharmaceutical
        2.14.1 Jiangzhong Pharmaceutical Details
        2.14.2 Jiangzhong Pharmaceutical Major Business
        2.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
        2.14.4 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Jiangzhong Pharmaceutical Recent Developments and Future Plans
    2.15 Yabao Pharmaceutical
        2.15.1 Yabao Pharmaceutical Details
        2.15.2 Yabao Pharmaceutical Major Business
        2.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
        2.15.4 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Yabao Pharmaceutical Recent Developments and Future Plans
    2.16 Jumpcan Pharmaceutical
        2.16.1 Jumpcan Pharmaceutical Details
        2.16.2 Jumpcan Pharmaceutical Major Business
        2.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
        2.16.4 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Jumpcan Pharmaceutical Recent Developments and Future Plans
    2.17 Hansen Pharmaceutical
        2.17.1 Hansen Pharmaceutical Details
        2.17.2 Hansen Pharmaceutical Major Business
        2.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
        2.17.4 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Hansen Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Pediatric Gastrointestinal Drugs Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Pediatric Gastrointestinal Drugs by Company Revenue
        3.2.2 Top 3 Pediatric Gastrointestinal Drugs Players Market Share in 2023
        3.2.3 Top 6 Pediatric Gastrointestinal Drugs Players Market Share in 2023
    3.3 Pediatric Gastrointestinal Drugs Market: Overall Company Footprint Analysis
        3.3.1 Pediatric Gastrointestinal Drugs Market: Region Footprint
        3.3.2 Pediatric Gastrointestinal Drugs Market: Company Product Type Footprint
        3.3.3 Pediatric Gastrointestinal Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Pediatric Gastrointestinal Drugs Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Pediatric Gastrointestinal Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Pediatric Gastrointestinal Drugs Consumption Value Market Share by Application (2019-2024)
    5.2 Global Pediatric Gastrointestinal Drugs Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2030)
    6.2 North America Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2030)
    6.3 North America Pediatric Gastrointestinal Drugs Market Size by Country
        6.3.1 North America Pediatric Gastrointestinal Drugs Consumption Value by Country (2019-2030)
        6.3.2 United States Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        6.3.3 Canada Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        6.3.4 Mexico Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2030)
    7.2 Europe Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2030)
    7.3 Europe Pediatric Gastrointestinal Drugs Market Size by Country
        7.3.1 Europe Pediatric Gastrointestinal Drugs Consumption Value by Country (2019-2030)
        7.3.2 Germany Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        7.3.3 France Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        7.3.5 Russia Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        7.3.6 Italy Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region
        8.3.1 Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Region (2019-2030)
        8.3.2 China Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        8.3.3 Japan Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        8.3.4 South Korea Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        8.3.5 India Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        8.3.7 Australia Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2030)
    9.2 South America Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2030)
    9.3 South America Pediatric Gastrointestinal Drugs Market Size by Country
        9.3.1 South America Pediatric Gastrointestinal Drugs Consumption Value by Country (2019-2030)
        9.3.2 Brazil Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        9.3.3 Argentina Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country
        10.3.1 Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Country (2019-2030)
        10.3.2 Turkey Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)
        10.3.4 UAE Pediatric Gastrointestinal Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Pediatric Gastrointestinal Drugs Market Drivers
    11.2 Pediatric Gastrointestinal Drugs Market Restraints
    11.3 Pediatric Gastrointestinal Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Pediatric Gastrointestinal Drugs Industry Chain
    12.2 Pediatric Gastrointestinal Drugs Upstream Analysis
    12.3 Pediatric Gastrointestinal Drugs Midstream Analysis
    12.4 Pediatric Gastrointestinal Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Pediatric Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Pediatric Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Pediatric Gastrointestinal Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Pediatric Gastrointestinal Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
    Table 6. AstraZeneca Major Business
    Table 7. AstraZeneca Pediatric Gastrointestinal Drugs Product and Solutions
    Table 8. AstraZeneca Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. AstraZeneca Recent Developments and Future Plans
    Table 10. Sanofi Company Information, Head Office, and Major Competitors
    Table 11. Sanofi Major Business
    Table 12. Sanofi Pediatric Gastrointestinal Drugs Product and Solutions
    Table 13. Sanofi Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Sanofi Recent Developments and Future Plans
    Table 15. Aptalis Company Information, Head Office, and Major Competitors
    Table 16. Aptalis Major Business
    Table 17. Aptalis Pediatric Gastrointestinal Drugs Product and Solutions
    Table 18. Aptalis Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Aptalis Recent Developments and Future Plans
    Table 20. Eisai Company Information, Head Office, and Major Competitors
    Table 21. Eisai Major Business
    Table 22. Eisai Pediatric Gastrointestinal Drugs Product and Solutions
    Table 23. Eisai Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Eisai Recent Developments and Future Plans
    Table 25. Pfizer Company Information, Head Office, and Major Competitors
    Table 26. Pfizer Major Business
    Table 27. Pfizer Pediatric Gastrointestinal Drugs Product and Solutions
    Table 28. Pfizer Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Pfizer Recent Developments and Future Plans
    Table 30. Zeria (Tillotts) Company Information, Head Office, and Major Competitors
    Table 31. Zeria (Tillotts) Major Business
    Table 32. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product and Solutions
    Table 33. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Zeria (Tillotts) Recent Developments and Future Plans
    Table 35. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 36. GlaxoSmithKline Major Business
    Table 37. GlaxoSmithKline Pediatric Gastrointestinal Drugs Product and Solutions
    Table 38. GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. GlaxoSmithKline Recent Developments and Future Plans
    Table 40. Salix Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 41. Salix Pharmaceuticals Major Business
    Table 42. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product and Solutions
    Table 43. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Salix Pharmaceuticals Recent Developments and Future Plans
    Table 45. Perrigo Company Information, Head Office, and Major Competitors
    Table 46. Perrigo Major Business
    Table 47. Perrigo Pediatric Gastrointestinal Drugs Product and Solutions
    Table 48. Perrigo Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Perrigo Recent Developments and Future Plans
    Table 50. Abbott Company Information, Head Office, and Major Competitors
    Table 51. Abbott Major Business
    Table 52. Abbott Pediatric Gastrointestinal Drugs Product and Solutions
    Table 53. Abbott Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Abbott Recent Developments and Future Plans
    Table 55. Honz Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 56. Honz Pharmaceutical Major Business
    Table 57. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
    Table 58. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Honz Pharmaceutical Recent Developments and Future Plans
    Table 60. Shandong DYNE Marine Biopharmaceutical Company Information, Head Office, and Major Competitors
    Table 61. Shandong DYNE Marine Biopharmaceutical Major Business
    Table 62. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
    Table 63. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Shandong DYNE Marine Biopharmaceutical Recent Developments and Future Plans
    Table 65. Sunflower Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 66. Sunflower Pharmaceutical Major Business
    Table 67. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
    Table 68. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Sunflower Pharmaceutical Recent Developments and Future Plans
    Table 70. Jiangzhong Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 71. Jiangzhong Pharmaceutical Major Business
    Table 72. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
    Table 73. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Jiangzhong Pharmaceutical Recent Developments and Future Plans
    Table 75. Yabao Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 76. Yabao Pharmaceutical Major Business
    Table 77. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
    Table 78. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 79. Yabao Pharmaceutical Recent Developments and Future Plans
    Table 80. Jumpcan Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 81. Jumpcan Pharmaceutical Major Business
    Table 82. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
    Table 83. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 84. Jumpcan Pharmaceutical Recent Developments and Future Plans
    Table 85. Hansen Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 86. Hansen Pharmaceutical Major Business
    Table 87. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product and Solutions
    Table 88. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Hansen Pharmaceutical Recent Developments and Future Plans
    Table 90. Global Pediatric Gastrointestinal Drugs Revenue (USD Million) by Players (2019-2024)
    Table 91. Global Pediatric Gastrointestinal Drugs Revenue Share by Players (2019-2024)
    Table 92. Breakdown of Pediatric Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 93. Market Position of Players in Pediatric Gastrointestinal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 94. Head Office of Key Pediatric Gastrointestinal Drugs Players
    Table 95. Pediatric Gastrointestinal Drugs Market: Company Product Type Footprint
    Table 96. Pediatric Gastrointestinal Drugs Market: Company Product Application Footprint
    Table 97. Pediatric Gastrointestinal Drugs New Market Entrants and Barriers to Market Entry
    Table 98. Pediatric Gastrointestinal Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 99. Global Pediatric Gastrointestinal Drugs Consumption Value (USD Million) by Type (2019-2024)
    Table 100. Global Pediatric Gastrointestinal Drugs Consumption Value Share by Type (2019-2024)
    Table 101. Global Pediatric Gastrointestinal Drugs Consumption Value Forecast by Type (2025-2030)
    Table 102. Global Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2024)
    Table 103. Global Pediatric Gastrointestinal Drugs Consumption Value Forecast by Application (2025-2030)
    Table 104. North America Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 105. North America Pediatric Gastrointestinal Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 106. North America Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 107. North America Pediatric Gastrointestinal Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 108. North America Pediatric Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 109. North America Pediatric Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 110. Europe Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 111. Europe Pediatric Gastrointestinal Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 112. Europe Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 113. Europe Pediatric Gastrointestinal Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 114. Europe Pediatric Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 115. Europe Pediatric Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 116. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 117. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 118. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 119. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 120. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 121. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 122. South America Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 123. South America Pediatric Gastrointestinal Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 124. South America Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 125. South America Pediatric Gastrointestinal Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 126. South America Pediatric Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 127. South America Pediatric Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 128. Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 129. Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 130. Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 131. Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 132. Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 133. Middle East & Africa Pediatric Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 134. Pediatric Gastrointestinal Drugs Raw Material
    Table 135. Key Suppliers of Pediatric Gastrointestinal Drugs Raw Materials
List of Figures
    Figure 1. Pediatric Gastrointestinal Drugs Picture
    Figure 2. Global Pediatric Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Pediatric Gastrointestinal Drugs Consumption Value Market Share by Type in 2023
    Figure 4. Tablets
    Figure 5. Pills
    Figure 6. Oral Liquid
    Figure 7. Global Pediatric Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Pediatric Gastrointestinal Drugs Consumption Value Market Share by Application in 2023
    Figure 9. Hospital Pharmacies Picture
    Figure 10. Online Pharmacies Picture
    Figure 11. Retail Pharmacies Picture
    Figure 12. Global Pediatric Gastrointestinal Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Pediatric Gastrointestinal Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market Pediatric Gastrointestinal Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global Pediatric Gastrointestinal Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global Pediatric Gastrointestinal Drugs Consumption Value Market Share by Region in 2023
    Figure 17. North America Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global Pediatric Gastrointestinal Drugs Revenue Share by Players in 2023
    Figure 23. Pediatric Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players Pediatric Gastrointestinal Drugs Market Share in 2023
    Figure 25. Global Top 6 Players Pediatric Gastrointestinal Drugs Market Share in 2023
    Figure 26. Global Pediatric Gastrointestinal Drugs Consumption Value Share by Type (2019-2024)
    Figure 27. Global Pediatric Gastrointestinal Drugs Market Share Forecast by Type (2025-2030)
    Figure 28. Global Pediatric Gastrointestinal Drugs Consumption Value Share by Application (2019-2024)
    Figure 29. Global Pediatric Gastrointestinal Drugs Market Share Forecast by Application (2025-2030)
    Figure 30. North America Pediatric Gastrointestinal Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America Pediatric Gastrointestinal Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America Pediatric Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe Pediatric Gastrointestinal Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe Pediatric Gastrointestinal Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe Pediatric Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 40. France Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific Pediatric Gastrointestinal Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 47. China Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 50. India Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America Pediatric Gastrointestinal Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America Pediatric Gastrointestinal Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America Pediatric Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa Pediatric Gastrointestinal Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa Pediatric Gastrointestinal Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa Pediatric Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE Pediatric Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 64. Pediatric Gastrointestinal Drugs Market Drivers
    Figure 65. Pediatric Gastrointestinal Drugs Market Restraints
    Figure 66. Pediatric Gastrointestinal Drugs Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Pediatric Gastrointestinal Drugs in 2023
    Figure 69. Manufacturing Process Analysis of Pediatric Gastrointestinal Drugs
    Figure 70. Pediatric Gastrointestinal Drugs Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AstraZeneca
Sanofi
Aptalis
Eisai
Pfizer
Zeria (Tillotts)
GlaxoSmithKline
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Hansen Pharmaceutical

Related Reports

Global Pediatric Gastrointestinal Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Pediatric Gastrointestinal Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 10 Feb 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pediatric Gastrointestinal Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Pediatric Gastrointestinal Drugs Supply, Demand and Key Producers, 2023-2029

Global Pediatric Gastrointestinal Drugs Supply, Demand and Key Producers, 2023-2029

date 19 Mar 2023

date Pharma & Healthcare

The global Pediatric Gastrointestinal Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Product Tags

Pediatric Gastrointestinal Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>